Bionik Laboratories Corp. Quarterly Debt-to-equity in % from Q2 2012 to Q1 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Bionik Laboratories Corp. quarterly Debt-to-equity history and growth rate from Q2 2012 to Q1 2023.
  • Bionik Laboratories Corp. Debt-to-equity for the quarter ending March 31, 2023 was -34.8K %, a 4744% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2023 -34.8K -35.6K -4744% Mar 31, 2023
Q4 2022 258 -519 -66.8% Dec 31, 2022
Q3 2022 2.96K +2.67K +921% Sep 30, 2022
Q2 2022 1.02K Jun 30, 2022
Q1 2022 750 Mar 31, 2022
Q4 2021 777 Dec 31, 2021
Q3 2021 290 Sep 30, 2021
Q1 2017 23.2 -829 -97.3% Mar 31, 2017
Q4 2016 23.7 -711 -96.8% Dec 31, 2016
Q3 2016 36 -763 -95.5% Sep 30, 2016
Q2 2016 77.7 -285 -78.6% Jun 30, 2016
Q1 2016 852 Mar 31, 2016
Q4 2015 735 Dec 31, 2015
Q3 2015 799 Sep 30, 2015
Q2 2015 363 Jun 30, 2015
Q2 2012 -15.1* Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.